Lipid Disorders
Feature
Tirzepatide scores win in second obesity trial, SURMOUNT-2
Tirzepatide (Mounjaro) met its primary endpoints, compared with placebo, in the SURMOUNT-2 trial, designed to test weight-loss efficacy, in top-...
Conference Coverage
Meditation curbs stress, depression as adjunct to CAD rehab
Adding a meditation session also improved quality of life by 60% in coronary artery disease patients.
From the Journals
Green Mediterranean diet may relieve aortic stiffness
A green Mediterranean diet high in polyphenols promoted dramatic proximal aortic de-stiffening as assessed by MRI over 18 months.
Conference Coverage
Napping and AFib risk: The long and the short of it
Both long and short daily naps were linked to atrial fibrillation risk, but in different ways.
Conference Coverage
Cardiovascular disease deaths rise on and after high-pollution days
High levels of air pollution were linked to higher risk of death from MI and stroke in a Polish population.
Guidelines
AHA statement targets nuance in CVD risk assessment of women
Considering nonbiological and social factors when assessing CVD risk in women, particularly women of diverse races and ethnicities, is highlighted...
From the Journals
Statins don’t worsen muscle injury from moderately intense exercise
Statin users need not limit exercise out of concern that the drugs will worsen normal muscle pain or fatigue, a controlled study suggests.
From the Journals
High salt intake linked to atherosclerosis even with normal BP
From the Journals
Some diets better than others for heart protection
From the Journals
Subclinical CAD by CT predicts MI risk, with or without stenoses
Even without symptoms, more atherosclerosis by CT angiography means greater MI risk, which climbs even further if there are obstructive lesions....
Commentary
Is it time to stop treating high triglycerides?
There may be noncardiovascular reasons to treat hypertriglyceridemia.